ABSTRACT
The majority of tissue biospecimens are processed and stored as formalin-fixed paraffin-embedded (FFPE) tissue blocks because this method of fixation excellently preserves tissue morphology for long periods. Hundreds of clinical assays (mainly immunohistochemical but also polymerase chain reaction (PCR) and in situ hybridization based) have been validated using it. However, nucleic acids and proteins extracted from FFPE tissues are typically cross-linked, fragmented, and sometimes modified, making them less amenable to analysis compared to the less-degraded and unmodified analytes extracted from frozen tissue. 1 Although molecular biologists and protein biochemists prefer frozen biospecimens, frozen tissue is less amenable to immunohistochemistry and histologic staining than FFPE biospecimens, and the logistics of freezing, transporting, and storing frozen biospecimens are more complicated and expensive than doing so with FFPE blocks. The need for tissue preservative that will combine the advantages of formalin (practicability, low cost, and amenability to immunohistochemistry and histomorphology) with those of cryopreservation (amenability to molecular biology and proteomics) has resulted in the development of numerous nonformalin fixatives, but all have failed to gain widespread use because they fail in respect of at least one parameter. 2 The PAXgene Tissue fixative system, developed by PreAnalytiX (a joint venture between Qiagen and BD; Hombrechtikon, Switzerland) has generated significant interest because it has been designed to address these issues. Its development followed an extensive testing/screening process involving over 1,000 substances, combinations of substances, and existing fixatives. 3 It is an alcohol-based, noncrosslinking fixative, supplied in an easy-to-ship container consisting of two chambers, one containing a fixative solution and the other a stabilizing solution. Biospecimens are placed in standard tissue cassettes, immersed in the chamber containing fixative solution for 3 to 24 hours, then transferred to the chamber containing stabilizing solution, where they can remain for 7 days at room temperature (eg, during shipping), 4 weeks at 4°C, or for a longer (but currently unspecified) period of time at −20°C or −80°C. Stabilized tissues can be processed and embedded in paraffin to make PAXgene-fixed paraffin-embedded (PFPE) tissue blocks, from which sections can be cut and used for immunohistochemistry, histomorphology, or DNA/RNA/protein extraction.
PAXgene Tissue fixative has been evaluated in several publications with inconsistent results and conclusions. ❚Table 1❚ summarizes these studies. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] PFPE sections have been found to offer both comparable and poorer histomorphological detail compared to FFPE sections, and comparable immunohistochemistry for most (but not all) antibodies tested after protocol optimization. [3] [4] [5] [6] [7] [8] [9] [10] For molecular biology, publications show PFPE biospecimens consistently yielding DNA that is of comparable quality to cryopreserved biospecimens and RNA that is sometimes comparable to cryopreserved biospecimens but sometimes poorer in quality. [3] [4] [5] [7] [8] [9] [10] [11] [12] [13] For proteomics and phosphoproteomics, PFPE is better than FFPE for "top down" applications using intact proteins (eg, western blotting, protein arrays, and two-dimensional electrophoresis) but not for "bottom up" mass spectrometry that analyses peptides (not intact proteins) using tandem mass spectrometry. 3, 9, 12, 14, 15 Although the PAXgene Tissue fixative has been evaluated, the studies published to date have used biospecimens collected shortly before analysis. It is not clear how resilient PFPE tissue blocks are to longer-term storage. We address this issue by comparing histology and the integrity of RNA and microRNA (miRNA) extracted from PFPE blocks just after they were made with that extracted from the same blocks after 7 years of storage. RNA was selected as the analyte to test because it is likely the least robust analyte.
Materials and Methods
A graphical representation of the experimental design is shown in ❚Figure 1❚.
Twenty-five clinical biospecimens were used in this study (11 breast tumor, five liver, three prostate, and one each of normal renal, pelvic mass tumor, normal colon, ovary tumor, myometrium tumor, and adrenal gland [Cushing syndrome] ). Tissues were obtained with written patient consent from three UK hospitals via the Wales Cancer Bank and the Imperial College NHS Trust Tissue Bank. Ethical approval was issued by the Imperial College NHS Trust Tissue Bank Ethics Committee. The tissues (visually 1.5 × 1.0 × 0.5 cm) were fixed, in 2009, using the PAXgene Tissue fixation system (PreAnalytiX) according to manufacturer's protocol, then embedded in paraffin to make PFPE blocks. These PFPE blocks were used in a previous study evaluating the PAXgene Tissue fixation system. 9 RNA and miRNA were separately extracted using the PAXgene Tissue RNA kit and PAXgene Tissue miRNA kits respectively (both PreAnalytiX), in 2009, from one deparaffinized 20-µm section per PFPE block. The optional DNase step was included. Immediately after its extraction (in 2009), the purified RNA was quality assessed using RNA integrity numbers (RINs) generated on RNA 6000 Nano or Pico chips that were run on a Bioanalyzer (all Agilent Technologies, Cork, Ireland). RINs range from 1 (RNA completely degraded) to 10 (RNA completely intact). The purified RNA was then stored at −80°C and the PFPE blocks stored in the dark at room temperature.
Seven years later (in 2016), RNA and miRNA were again extracted from the same blocks (but from five sections of 10 µm) using the same protocols. No sections had been taken from the blocks between 2009 and 2016. Both the 2009 and 2016-extracted RNA and miRNA were quantified by OD 260 nm spectrophotometry and their purities assessed using OD 260:280 and 260:230 on a Synergy Mx (BioTek Instruments, Bad Friedrichshall, Germany).
Equal quantities of RNA from the 2009 and 2016 extractions from each PFPE block (n = 17) were again assessed by Agilent Bioanalyzer and, in addition to RIN, the paraffin-embedded RNA metric (PERM) value was calculated. PERM is calculated using the number of fluorescence units in the Bioanalyzer electropherogram at nine specified time points during a sample's run but with a progressive weighting in favor of later time points (generated by larger RNA fragments); thus, higher PERM values equate to samples of greater integrity. 16 Unlike RIN, PERM is not influenced by the 18S and 28S rRNA peaks and it can only be applied to samples that have been paraffin-embedded (ie, where the rRNA peaks have degraded). RNA concentration is a critical parameter in the PERM algorithm (an increase in RNA concentration leads to an increase in fluorescence units and therefore a higher PERM), so an equal quantity of RNA (assessed using photometry) was run in the Bioanalyzer chip for For size reverse transcription polymerase chain reaction (RT-PCR), 25 ng to 1 µg RNA, depending on RNA availability from 2009 extractions (n = 18), were converted into cDNA in a total volume of 20 µL per reaction using random primers and the High Capacity cDNA Reverse Transcription kit (ThermoFisher Scientific, Foster City, CA) on a C1000 PCR thermal cycler (Bio-Rad, Hercules, CA). The same quantity of RNA was always used in sample-matched 2009 and 2016 extractions. Thirty or 32 cycles of PCR (depending on the amplicon) was then carried out using the FastStart High Fidelity PCR kit (Roche, Mannheim, Germany), 2 µL of cDNA, and a combination of one of four forward primers plus one reverse primer to obtain 65, 256, 584, and 942 base pair (bp) amplicons of the hydroxymethylbilane synthase (HMBS) gene. Results were visualized by electrophoresis on a 1.5% agarose gel, stained with GelRed (Biotium, Hayward, CA) and imaged on a ImageQuant LAS 4000 (GE Healthcare, Diegem, Belgium).
Aliquots containing 25 ng RNA were also used for quantitative RT-PCR (qRT-PCR) analysis. After cDNA conversion using the protocol described above, 10 cycles of preamplification PCR were carried out using 12.5 µL of cDNA, TaqMan PreAmp Master Mix, and a pooled assay mix of TaqMan Gene Expression Assays Hs01060665_g1, Hs02758991_g1, and Hs00609296_g1 specific for β-actin, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and HMBS, respectively (all Applied Biosystems). Then, 1 µL preamplified cDNA was further amplified by real-time PCR, with the same TaqMan probes as previously mentioned, using a 7500 real-time PCR system and analyzed using SDS version 1.4.2 software (all Applied Biosystems). Each sample was run in triplicate and the mean of the threshold cycle (Ct) values taken for data analysis.
miRNA was also evaluated using qRT-PCR. For each assay, 10 ng miRNA was transcribed using the miRNA Reverse Transcription kit (ThermoFisher) in a total volume of 15 µL, then real-time PCR was performed with 1.33 µL of cDNA in a total volume of 20 µL per reaction using TaqMan assay IDs 001001, 000391, and 000524, specific for RNU-24, miR-16, and miR-221 respectively (all Applied Biosystems). Each sample was run in triplicate and the mean of the raw Ct values taken for data analysis.
Morphologic analysis was carried out on all blocks in 2016. Sections of 4 µm thickness were dried onto slides for 30 minutes at 65°C then stained on a Shandon Varistain Gemini (ThermoFisher Scientific) according to a routine hematoxylin eosin saffron (HES) protocol for FFPE sections. Slides were dewaxed, rehydrated with successive applications of xylene substitute, alcohol (100%, 95%, and 70%), then water. Hematoxylin (Sakura Tissue Tek, Alphen aan den Rijn, Netherlands) was applied for 4 minutes followed by a 15-second differentiation in 1% acid alcohol after which bluing reagent 
Results
In order to determine if the purified RNA extracted from the PFPE blocks in 2009 had degraded during its 7 years of storage at −80°C, RINs obtained before and after storage were compared. There were 14 extractions where data from 2009 were available, and the mean RIN of these samples was 3.59 in 2009 and 3.63 in 2016. A paired t test (data were normally distributed) returned a P value of .83, so we concluded that the purified RNA had not degraded during storage.
Bioanalyzer electropherograms were used to measure RNA degradation using two different algorithms: RIN and normalized PERM. In both RIN and normalized PERM, RNA extracted in 2009 from the PFPE blocks was of higher integrity than that extracted in 2016 ❚Figure 2❚. Median RIN decreased from 3.6 in the 2009 extractions to 2.0 in the 2016 extractions (P < .001) and median normalized PERM from 0.0185 to 0.0140 (P = .008). The reduction of RIN per sample varied between 1 RIN unit and 2.3 RIN units (mean 1.8 RIN units).
In the size RT-PCR analysis, where different amplicon lengths of the HMBS transcript were amplified using endpoint PCR, the longest amplicon (942 bp) was obtained from seven PFPE blocks (39% of the total number of blocks analyzed) for the 2009 extractions. However, when RNA had been extracted in 2016 from the same blocks, no 942-bp amplicons could be generated ❚Figure 3❚. A further seven PFPE blocks (39% of the total) yielded the 584-bp amplicon in 2009, but of these only one also did so in 2016 (6% of the total). Of the four remaining PFPE blocks, one yielded a 256-bp amplicon in 2009 but failed to yield any amplicons in 2016, one yielded a higher amplicon in 2016 (256 bp) compared with 2009 (65 bp), one yielded a 65-bp amplicon in both years, and one failed to yield an amplicon in either 2009 or 2016. Therefore, mRNA integrity in PFPE blocks had declined during the 7 years of storage, with the percentage of PFPE blocks that yielded amplicons 584 bp or longer reducing from 78% in 2009 to 6% in 2016.
For qRT-PCR from mRNA, for each of the three genes tested, Cts were higher (denoting more degraded RNA) in the 2016 extractions compared to 2009 extractions ❚Figure 4A❚. The mean increase in Ct values in 2016 extractions compared to 2009 extractions was 1.2 for β-actin (P = .04), 2.5 for GAPDH (P < .001), and 2.4 for HMBS (P = .002).
A consequence of different transcripts in the same PFPE block having different degradation rates would be an inability to reliably carry out normalization to a reference gene in the commonly used ∆∆Ct technique in qRT-PCR. This method assumes that the ratio between the Ct of the reference gene and each target gene is stable in respect of preanalytical variables such as storage time. In order to assess the likely impact of inconsistent transcript degradation rates on such reference gene normalization, we compared the three intergene ∆Ct values (ie, Ct GAPDH-Ct β-actin, Ct HMBS-Ct GAPDH, and Ct HMBS-Ct β-actin) for the 2009 extractions and the 2016 extractions ❚Figure 4B❚. Storing the PFPE blocks for 7 years caused mean ∆Ct to increase from 1.7 to 3.9 for GAPDH-β-actin (P < .001) and from 8.2 to 9.4 for HMBS-β-actin (P < .001); only the ∆Ct for HMBS-GAPDH remained the same before and after the blocks' storage (mean ∆Ct was 6.4 in 2009 extractions and 6.3 in 2016 extractions, P = .44). The relative stability of β-actin to storage compared to GAPDH and HMBS (which both degraded faster than β-actin but at a comparable rate to each other) was the reason why only the ∆Ct HMBS-GAPDH was consistent in 2009 and 2016 extractions. Amplicon lengths in the TaqMan probes is unlikely to account for the difference seen because the β-actin and HMBS assays generated comparably sized amplicons (63 and 69 bp, respectively) while the GAPDH TaqMan assay's amplicon was slightly longer (93 bp).
In addition to qRT-PCR, HMBS was also the gene analyzed in the size RT-PCR experiment, with the RefSeq transcript variant used for the size RT-PCR assay (NM_000190.3) being one of the nine HMBS transcript variants amplified in the TaqMan assay. The 69 bp TaqMan amplicon was of comparable size to the smallest-size RT-PCR amplicon (65 bp), but its location in the transcript was different (the TaqMan amplicon forms part of the 942-bp RT-PCR amplicon). The sample run in both assays that failed to generate a 65-bp RT-PCR amplicon in the 2016 extractions (sample 15 in Figure 3 ) returned a Ct of 28.5 in the qRT-PCR experiment. Therefore, despite the lack of a visible band in the size RT-PCR gel electrophoresis, the RNA was not completely degraded. It was, however, more degraded than average, because the mean Ct of all remaining HMBS qRT-PCR 2016 extractions was 27.3.
In contrast to the mRNA, none of the three miRNAs analyzed by qRT-PCR showed such obvious degradation during 7 years of storage in PFPE blocks. Median Ct numbers showed no overall change between the years ❚Figure 5❚. Mean Ct numbers increased in all three genes (from 27.2 to 29.5 for RNU24, from 24.9 to 25.0 for miR-16, and from 28.8 to 29.3 for miR-221); however, with the increase in Ct falling just short of statistical significance (P > .09). Although a larger sample size might result in the increase in Ct in poststored blocks becoming statistically significant, it is clear that miRNA is more resilient than mRNA to storage in PFPE blocks.
A histomorphological evaluation using 4-µm sections stained with HES found that the tissue morphology to be equally well preserved in sections taken in 2016 as it was in scanned images taken in 2009 ❚Image 1❚. However, images of H&E-stained sections from 2009 were not available for all the blocks, the staining in 2016 was carried out in a different laboratory using a different 
Discussion
This study demonstrates that mRNA in PFPE blocks stored in the dark at room temperature degrades over 7 years in storage. The mRNA degradation was apparent in every block and in all of the assays (RIN, PERM, conventional RT-PCR for different amplicon lengths, and qRT-PCR). It can be summarized as a reduction in RIN of 1.8 units, a reduction in the likelihood of a block having a transcript length of at least 584 bp from 78% to 5%, and an increase in qRT-PCR Ct of 1.2 to 2.5 units for the three genes analyzed. This loss of mRNA integrity is particularly unwelcome in the context of clinical biospecimens (ie, those with variable and often uncontrolled preanalytical variables), where the mRNA quality in PFPE blocks is already suboptimal compared to the equivalent cryopreserved tissue before the storage had even begun. 9, 12 In contrast to mRNA, miRNA was more stable, with a slight reduction in miRNA integrity that was small in magnitude, falling just short of statistical significance. It is noteworthy that in addition to its improved stability during storage, publications have shown that miRNA integrity, unlike mRNA integrity, is the same when extracted from sample-matched fresh-frozen and PFPE biospecimens (Table 1) .
Histomorphological features did not degrade during storage, although the H&E staining was less eosinophilic in 2016 compared to 2009. We think this is more likely © American Society for Clinical Pathology attributable to differences in the staining protocols and imaging equipment than storage. Indeed, the extent of the more intense eosinophilic coloring that characterizes H&E staining in PFPE sections appears to be protocol dependent because some labs report the phenomenon and some do not (Table 1) . RINs are a commonly used metric of mRNA quality, familiar to many researchers, and three different publications have defined a minimum RIN threshold of 5, 6, or 7 that define a sample's amenability to transcript microarray analysis. [17] [18] [19] Four of the 17 samples in our study exceeded the lower threshold of RIN 5 at the commencement of storage, but 7 years later none had RINs higher than 2.3, suggesting that the poststorage PFPE blocks would no longer be amenable to microarray analysis. However, FFPE samples, which only yield highly fragmented RNA, are demonstrably amenable to microarray analysis. 20 Although the RINs less than 3 that we found in poststored PFPE blocks are what would be expected from FFPE samples, they were lower than we would expect to see from a fixative that is designed to preserve nucleic acid. The RIN algorithm relies heavily on the respective degradation states of the 18S and 28s rRNA subunits and is therefore not a direct measure of © American Society for Clinical Pathology mRNA integrity. Indeed, a previous study has shown that mRNA integrity can be much higher in very degraded cryopreserved biospecimens than in sample-matched FFPE blocks that have equally low RINs, with the cryopreserved biospecimens returning RT-PCR amplicons of at least 584 bp as opposed to maximum amplicons of 256 bp in the sample-matched FFPE blocks, despite their similar RINs of less than 3. 21 In our PFPE study, we found that the RT-PCR amplicon lengths generated from the PFPE blocks that had been in storage for 7 years were of a length expected of FFPE samples, and shorter than were found in highly degraded frozen samples. With one exception, maximum amplicon lengths were 256 bp or less, despite 942-bp amplicons having been successfully generated from 39% of the blocks 7 years earlier.
The genes that we selected for qRT-PCR are common housekeeping genes and as such should be stable in expression. However, stability evaluations for housekeeping genes typically use frozen tissue and restrict the evaluated stability parameters to different tissue types and/ or experimental conditions. Few studies have evaluated housekeeping gene stability in respect of fixed (not frozen) biospecimens embedded in paraffin and stored at room temperature, and even fewer have included storage time as a parameter for evaluation. Aggerholm-Pedersen et al 22 measured degradation of the peptidylprolyl isomerase A (PPIA), splicing factor 3a subunit 1 (SF3A1), and mitochondrial ribosomal protein L19 (MRPL19) housekeeping genes in FFPE sarcoma tissue blocks over 10 years using qRT-PCR, finding that Ct increased at a rate of 0.37 per year in each of the three genes. Tramm et al 23 analyzed expression of 16 housekeeping genes (including β-actin, GAPDH, and HMBS) in 40 FFPE breast blocks stored for up to 29 years, and similarly found that although Ct numbers increased with storage time, this was consistent between genes in the same tissue block, so ∆Δ Ct calculations would not be influenced by storage time. In a third study, the 3′ to 5′ ratio of actin extracted from FFPE blocks was found not to be influenced by the block's storage time. 24 The mRNA degradation rates we found in PFPE blocks, assessed in terms of the increase in Ct per year, are broadly concordant with those found in the aforementioned studies using FFPE. In our study, β-actin increased at a rate of 0.17 Ct per year in PFPE, whilst AggerholmPedersen et al 22 found it increasing at 0.22 Ct per year in FFPE blocks. We found GAPDH and HMBS in PFPE to degrade at 0.35 and 0.34 Ct per year respectively, which is very similar to the 0.37 Ct per year Tramm et al 23 found with PPIA, SF3A1, and MRPL19. Degradation rates of mRNA in FFPE blocks will be influenced by preanalytical variables (eg, tissue type, type of formalin buffer, fixation time, and the temperature and humidity that the block is held at during storage). Consequently, the different degradation rates reported in the two studies evaluating FFPE is not surprising. However, despite these betweenstudy differences, it is important to note that the previous studies using FFPE commonly report the finding that in the housekeeping genes they have evaluated, different transcripts from the same FFPE block degrade at a constant rate, regardless of the period of time the block has been in storage. Consequently, in FFPE tissue blocks, the rate and effect of mRNA degradation over time becomes inconsequential in ∆∆Ct analyses because expression of target genes are normalized to at least one reference gene from the same FFPE block. Therefore, research projects can be reliably carried out using a cohort of FFPE blocks that have been in storage for different periods of time.
It is difficult to come to the same conclusion with PFPE blocks, however, because we have found that the different genes degrade at different rates in the same block, and it will therefore be difficult to normalize for storage time when carrying out mRNA analyses using PAXgenefixed tissue. We see no reason why this issue of inconsistent mRNA degradation during storage should just apply to the PAXgene tissue fixative however, and recommend ❚Figure 5❚ Quantitative reverse transcription polymerase chain reaction of RNU24, miR16, and miR221. MicroRNA (miRNA) was extracted from the same PAXgene-fixed paraffin-embedded blocks in 2009 and in 2016. For each of the miRNAs, there were no statistically significant differences in Ct numbers between the two extractions carried out 7 years apart. The box represents the first and third quartiles, intersected by the median and the whiskers are the range. It is logical that storing PFPE blocks at lower temperatures would reduce the rate of degradation. Indeed, PreAnalytiX currently recommend that PFPE blocks be stored at lower than ambient temperatures. One previous study noted that protein yield declined by an average of 9% in PFPE blocks after storage for 1 year, with storage temperature (room temperature and 4°C were evaluated) not being influential in the decline.
14 An abstract from a conference reports both RNA and DNA but not tissue morphology degrading over 48 months in PFPE blocks stored at both room temperature and 4°C, but not at −20°C, but unfortunately no data were provided. 25 Consequently, we think that while lowering the storage temperature might reduce the rate that RNA degrades in the blocks, we doubt that it will prevent it from occurring. In our experience, FFPE blocks can be stored at −20°C but not at −80°C, with the latter temperature sometimes causing the paraffin to crack.
An option would therefore be to store biospecimens in PAXgene Tissue stabilizing solution at −80°C rather than as PFPE blocks. Indeed, in the Genotype-Tissue Expression (GTEx) project, postmortem tissue is fixed in PAXgene, then the biospecimens are cut in two after stabilization, with one portion being used to make a PFPE block for pathology and the other portion being placed unembedded in PAXgene stabilizing solution for storage at −80°C. 26 By restricting the postmortem time interval (time of death to tissue fixation) to less than 8 hours, then extracting RNA shortly after the sample is received at the processing center, and not subjecting the tissue to the additional degradation incurred during processing and embedding, GTEx obtain high-quality RNA with RINs above 6.7. 27 We are unaware of any publications that address the long-term stability of biospecimens stored in PAXgene stabilizing solution at −80°C, and so users adopting this method of cryopreservation are taking a risk that long-term storage is not viable. This is in marked contrast to the situation with conventional fresh-frozen biospecimens, where long-term storage at −80°C has been validated for several tissue types. 21, 28, 29 However, PreAnalytiX appears to be conducting a longterm stability study; they initially stated that tissue can be stored in stabilizing solution at −80°C without negative effects on tissue morphology or nucleic acid integrity for "at least 3 months" (DNA kit handbook, 2009), but this time period has now been extended to "several years"
(https://www.preanalytix.com/products/tissue/ fixation-stabilization).
We conclude that the PAXgene Tissue fixation system is viable and practical in specific circumstances. The literature relating to it is now reasonably extensive (Table 1) , and this accumulating body of evidence adequately describes PAXgene's advantages and limitations. We recommend tissue banks collect separate fresh-frozen and FFPE tissue blocks where possible rather than using PAXgene or other nonformalin fixatives, because doing so results in biospecimens that are most amenable to molecular biology, proteomics, and pathology. Sometimes, however, this is not feasible (eg, liquid nitrogen/dry ice might not be available or the tissue biospecimens could be too small for more than one block to be taken). In such situations, PAXgene is an attractive and viable alternative, provided the downstream analytical technique precludes the use of FFPE and any immunohistochemical or histologic protocols to be used have been validated on PAXgene. If PAXgene is to be used and the biospecimens stored in the PFPE format, we recommend that users perform nucleic acid extractions as early as possible (ideally, before the samples are processed into PFPE blocks). The nucleic acid can then be stored at −80°C until required. This is particularly important for mRNA, because in PFPE blocks different transcripts appear to degrade at different rates during storage.
